Populations of Tau Conformers Drive Prion-like Strain Effects in Alzheimer's Disease and Related Dementias.
Lenka HromadkovaMohammad Khursheed SiddiqiHe LiuJiri G SafarPublished in: Cells (2022)
Recent findings of diverse populations of prion-like conformers of misfolded tau protein expand the prion concept to Alzheimer's disease (AD) and monogenic frontotemporal lobar degeneration (FTLD)-MAPT P301L, and suggest that distinct strains of misfolded proteins drive the phenotypes and progression rates in many neurodegenerative diseases. Notable progress in the previous decades has generated many lines of proof arguing that yeast, fungal, and mammalian prions determine heritable as well as infectious traits. The extraordinary phenotypic diversity of human prion diseases arises from structurally distinct prion strains that target, at different progression speeds, variable brain structures and cells. Although human prion research presents beneficial lessons and methods to study the mechanism of strain diversity of protein-only pathogens, the fundamental molecular mechanism by which tau conformers are formed and replicate in diverse tauopathies is still poorly understood. In this review, we summarize up to date advances in identification of diverse tau conformers through biophysical and cellular experimental paradigms, and the impact of heterogeneity of pathological tau strains on personalized structure- and strain-specific therapeutic approaches in major tauopathies.
Keyphrases
- cerebrospinal fluid
- endothelial cells
- escherichia coli
- cognitive decline
- induced apoptosis
- induced pluripotent stem cells
- pluripotent stem cells
- high resolution
- binding protein
- cell cycle arrest
- genome wide
- cell death
- signaling pathway
- dna methylation
- cell proliferation
- small molecule
- blood brain barrier
- functional connectivity
- pi k akt
- brain injury